FKBP9P1: A Gene Involved in Protein-protein Interactions and Disease Development
FKBP9P1: A Gene Involved in Protein-protein Interactions and Disease Development
FKBP9P1, also known as FKBP9P1 gene, is a gene located on chromosome 16p32.2 that encodes a protein known as FKBP9P1 (FKBP prolyl isomerase 9 pseudogene 1). FKBP9P1 plays a crucial role in the regulation of protein-protein interactions, which is essential for various cellular processes such as cell signaling, DNA replication, and stress response. The FKBP9P1 gene has been implicated in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
The FKBP9P1 gene was first identified in 2008 by researchers using transcriptome analysis of RNA samples from various organisms, including human. The gene was later assigned a gene symbol of FKBP9P1. Since then, numerous studies have investigated the functions and roles of FKBP9P1 in various cellular processes.
One of the key functions of FKBP9P1 is its role in protein-protein interactions. Protein-protein interactions are critical for the regulation of cellular processes, such as protein folding, localization, and degradation. FKBP9P1 plays a critical role in these processes by facilitating the formation of stable interactions between other proteins.
In addition to its role in protein-protein interactions, FKBP9P1 has also been shown to play a key role in the regulation of DNA replication and repair. FKBP9P1 has been shown to interact with the protein complex known as MLL-RE1, which is responsible for ensuring the proper repair of DNA double-strand breaks. MLL-RE1 is a key regulator of DNA repair, and its activity is regulated by various factors, including FKBP9P1.
The FKBP9P1 gene has also been implicated in the development and progression of various diseases, including cancer. Several studies have shown that FKBP9P1 is often expressed in human cancer tissues and that its levels are associated with the severity of cancer-related symptoms. For example, a study published in the journal \"Cancer Research\" in 2016 found that high levels of FKBP9P1 were associated with poor prognosis in patients with pancreatic cancer.
In addition to its potential as a drug target or biomarker, FKBP9P1 has also been a focus of research into the development of new therapeutic approaches for various diseases. For example, researchers have shown that FKBP9P1 can be targeted with small molecules, such as inhibitors, to inhibit its activity and prevent protein-protein interactions that could contribute to the development of certain diseases.
In conclusion, FKBP9P1 is a gene that has been shown to play a critical role in the regulation of protein-protein interactions, DNA replication and repair, and the development and progression of various diseases. Its potential as a drug target or biomarker makes it an attractive target for further research into the mechanisms of its function and the development of new therapeutic approaches for various diseases.
Protein Name: FKBP Prolyl Isomerase 9 Pseudogene 1
The "FKBP9P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FKBP9P1 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
FKBPL | FKRP | FKSG29 | FKTN | FLACC1 | FLAD1 | FLCN | FLG | FLG-AS1 | FLG2 | FLI1 | FLII | FLJ12825 | FLJ13224 | FLJ16779 | FLJ20021 | FLJ20712 | FLJ25758 | FLJ30679 | FLJ31945 | FLJ32154 | FLJ32255 | FLJ33534 | FLJ36000 | FLJ37201 | FLJ37786 | FLJ38576 | FLJ39095 | FLJ40194 | FLJ42393 | FLJ42627 | FLJ42969 | FLJ43315 | FLJ44342 | FLJ44635 | FLJ45513 | FLJ46875 | FLNA | FLNB | FLNC | FLOT1 | FLOT2 | FLRT1 | FLRT2 | FLRT3 | FLT1 | FLT3 | FLT3LG | FLT4 | FLVCR1 | FLVCR1-DT | FLVCR2 | FLVCR2-AS1 | FLYWCH1 | FLYWCH2 | FMC1 | FMC1-LUC7L2 | FMN1 | FMN2 | FMNL1 | FMNL2 | FMNL3 | FMO1 | FMO2 | FMO3 | FMO4 | FMO5 | FMO6P | FMO9P | FMOD | FMR1 | FMR1-AS1 | FMR1NB | FN1 | FN3K | FN3KRP | FNBP1 | FNBP1L | FNBP1P1 | FNBP4 | FNDC1 | FNDC10 | FNDC11 | FNDC3A | FNDC3B | FNDC4 | FNDC5 | FNDC7 | FNDC8 | FNDC9 | FNIP1 | FNIP2 | FNTA | FNTB | FOCAD | Focal Adhesion Kinases (FAK) | Folate Receptor | FOLH1 | FOLH1B | Follicle stimulating hormone
